The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma.
 
Andrew Jenho Yee
Consulting or Advisory Role - Adaptive Biotechnologies; Dexcel Pharma; Takeda
 
Jacob Laubach
Consulting or Advisory Role - Celgene; Novartis; Takeda
Research Funding - Celgene; Millennium; Novartis; Onyx
 
Erica Leigh Campagnaro
No Relationships to Disclose
 
Brea Lipe
Consulting or Advisory Role - celgene
Research Funding - Celgene (Inst); cellectar (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst)
 
Omar Nadeem
Consulting or Advisory Role - Genentech; GlaxoSmithKline; Takeda
 
Craig Cole
No Relationships to Disclose
 
Elizabeth O'Donnell
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Takeda
 
Robert L. Schlossman
Consulting or Advisory Role - Celgene; Takeda
 
Giada Bianchi
No Relationships to Disclose
 
Andrew Robert Branagan
No Relationships to Disclose
 
Samantha J. Shapiro
No Relationships to Disclose
 
Cynthia C. Harrington
No Relationships to Disclose
 
Jill N. Burke
No Relationships to Disclose
 
Marilyn T. Gammon
No Relationships to Disclose
 
Kathleen J. Lively
No Relationships to Disclose
 
Cassandra Ann Thorburn
No Relationships to Disclose
 
Mason L. Mann
No Relationships to Disclose
 
Jens Guenter Lohr
Consulting or Advisory Role - 4SC
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Takeda
Research Funding - Celgene; Takeda
 
Noopur S. Raje
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Merck; Novartis; Takeda
Research Funding - AstraZeneca (Inst)